Literature DB >> 10076560

Promotion by sodium L-ascorbate in rat two-stage urinary bladder carcinogenesis is dependent on the interval of administration.

T X Chen1, H Wanibuchi, T Murai, M Kitano, S Yamamoto, S Fukushima.   

Abstract

In our two-stage model of rat urinary bladder carcinogenesis employing N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) as the initiator, sodium L-ascorbate (Na-AsA) exhibits dose-dependent promotion. In the present study, in order to assess the possible reversibility of the promoting effects, we investigated how different administration periods of Na-AsA influence its promoting activity. In experiment 1, rats were treated with 5% Na-AsA for different administration periods with or without withdrawal and injected with 5-bromo-2'-deoxyuridine (BrdU) to allow determination of the cell proliferation status. Replicative DNA synthesis in the urinary bladder epithelium was shown to return to normal after removal of the promoting stimulus. In experiment 2, rats were initially given BBN for 4 weeks and subsequently received 16 weeks of Na-AsA, alternating with basal diet, at intervals of 4, 8 or 16 weeks, within a total 32-week period. The longer the continuous exposure to Na-AsA, the greater the yield of papillomas and carcinomas in the urinary bladder. In experiment 3, Na-AsA was given for 4 or 8 weeks after BBN initiation and the animals were killed at weeks 8 and 12. Both promotion of lesion development and increase of DNA synthesis in the urinary bladder epithelium were dependent on the length of exposure to Na-AsA and the total period of exposure. The results indicate that the promoting effects of Na-AsA in urinary bladder carcinogenesis are reversible to a certain extent after its withdrawal, and the existence of a cumulative exposure time threshold seems likely.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10076560      PMCID: PMC5925984          DOI: 10.1111/j.1349-7006.1999.tb00660.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


N‐butyl‐N‐(4‐hydroxybutyl)‐nitrosamine sodium L‐ascorbate 12‐O‐tetradecanoylphorbol‐13‐acetate 5‐bromo‐2′‐deoxyuridine basal diet papillary or nodular
  31 in total

Review 1.  Modification of tumor development in the urinary bladder.

Authors:  S Fukushima
Journal:  Prog Exp Tumor Res       Date:  1991

Review 2.  Promotion of urinary bladder carcinogenesis in experimental animals.

Authors:  N Ito; S Fukushima
Journal:  Exp Pathol       Date:  1989

3.  Effects of dose and time in a long-term, low-dose carcinogenic study.

Authors:  N A Littlefield; J H Farmer; D W Gaylor; W G Sheldon
Journal:  J Environ Pathol Toxicol       Date:  1980

Review 4.  Cell proliferation in carcinogenesis.

Authors:  S M Cohen; L B Ellwein
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

5.  Mechanisms of carcinogenesis: dose response.

Authors:  P J Gehring; G E Blau
Journal:  J Environ Pathol Toxicol       Date:  1978 Sep-Oct

6.  Comparative analysis of the proliferative response of the rat urinary bladder to sodium saccharin by light and scanning electron microscopy and autoradiography.

Authors:  S M Cohen; M J Fisher; T Sakata; M Cano; G P Schoenig; C I Chappel; E M Garland
Journal:  Scanning Microsc       Date:  1990-03

7.  Promoting effects of sodium L-ascorbate on two-stage urinary bladder carcinogenesis in rats.

Authors:  S Fukushima; K Imaida; T Sakata; T Okamura; M Shibata; N Ito
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

8.  Histopathological analysis of preneoplastic changes during N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis in rats.

Authors:  S Fukushima; G Murasaki; M Hirose; K Nakanishi; R Hasegawa; N Ito
Journal:  Acta Pathol Jpn       Date:  1982-03

9.  Lack of induction of epithelial cell proliferation by sodium saccharin and sodium L-ascorbate in the urinary bladder of NCI-black-Reiter (NBR) male rats.

Authors:  S Uwagawa; K Saito; Y Okuno; H Kawasaki; A Yoshitake; H Yamada; S Fukushima
Journal:  Toxicol Appl Pharmacol       Date:  1994-08       Impact factor: 4.219

10.  Nongenotoxic carcinogens: an extension of the perspective provided by Perera.

Authors:  J Ashby; I F Purchase
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.